Researchers have published, in JMIR Research Protocols, the design for a pilot randomized controlled trial evaluating CarePair, a mobile self-assessment and service referral platform aimed at family caregivers of people with Alzheimer's disease and related dementias (ADRD). According to the protocol, posted April 1, 2026, the study's primary objective is to test the feasibility and acceptability of the app among ADRD family caregivers, not yet its effectiveness at improving caregiver outcomes. The trial has not enrolled and reported results at time of writing; it is registered as a pilot, the phase meant to establish whether a study of this kind can be run and completed before a larger trial is attempted. The protocol frames the need this way: as dementia progresses, caregiving grows more complex and demanding, and home- and community-based services can supply skills and resources caregivers need, but connecting caregivers to those services in a timely way remains a persistent gap the CarePair platform is designed to address. Because this is a protocol paper describing planned methods, it reports no outcome data on whether the app actually shortens the time to service connection, reduces caregiver strain, or outperforms usual referral pathways; those questions are what the pilot itself is designed to begin answering once it enrolls and runs to completion.
Pilot Trial Registered to Test Whether an App Can Speed Caregivers to Services
JMIR Research Protocols has published the design for a pilot randomized controlled trial of CarePair, a mobile self-assessment and referral platform meant to connect family caregivers of people with Alzheimer's and related dementias to home and community services faster. No results exist yet: this is the trial's blueprint, not its findings.
Family caregivers or clinicians interested in the study can consult the published protocol or the trial's registration for eligibility criteria and enrollment status as the pilot moves forward; no enrollment numbers or completion date were reported in the protocol as published.